Phathom Pharmaceuticals Ratios (2022-2025) | PHAT

Ratios Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 75.51%77.72%81.21%85.59%87.14%86.94%87.25%87.50%
EBT Margin 1,473.65%898.50%550.61%572.35%410.48%426.08%425.90%-11,665.10%-4,331.01%-1,248.50%-523.29%-251.15%-330.64%-191.52%-60.53%
EBIT Margin 1,373.90%800.48%458.43%485.75%326.32%329.70%352.81%-10,245.60%-3,658.68%-1,055.43%-432.95%-200.30%-276.53%-151.69%-30.85%
EBITDA Margin 1,373.90%800.48%458.43%485.75%326.32%329.70%352.81%-10,245.60%-3,658.68%-1,055.43%-432.95%-200.30%-276.53%-151.69%-30.85%
Operating Margin 1,373.90%800.48%458.43%485.75%326.32%329.70%352.81%-10,245.60%-3,658.68%-1,055.43%-432.95%-200.30%-276.53%-151.69%-30.85%
Net Margin 1,473.65%898.50%550.61%572.35%410.48%426.08%425.90%-11,665.10%-4,331.01%-1,248.50%-523.29%-251.15%-330.64%-191.52%-60.53%
FCF Margin 1,626.57%460.40%378.89%431.71%432.71%230.95%325.05%-6,491.50%-3,611.92%-966.23%-389.05%-213.93%-297.96%-158.98%-28.57%
Efficiency
Inventory Average 0.11M0.66M1.33M1.82M2.64M3.16M3.19M3.30M3.52M
Assets Average 181.28M207.72M183.37M154.41M204.52M251.02M325.42M385.17M337.94M353.21M382.68M336.26M272.21M245.25M
Equity Average 15.52M-16.71M-50.62M-82.50M-36.30M-0.09M-45.27M-110.63M-191.17M-210.47M-220.35M-295.98M-372.11M-414.18M
Invested Capital 38.03M-7.00M-26.42M-74.81M-90.19M17.60M-17.77M-72.76M-148.50M-233.83M-187.11M-253.58M-338.38M-405.83M-422.53M
Asset Utilization Ratio -0.15-0.22-0.18-0.15-0.09-0.040.000.070.140.240.420.60
Leverage & Solvency
Interest Coverage Ratio -13.74-8.00-4.58-4.86-3.26-3.30-3.53-5.36-4.07-4.35-3.83-3.20-4.36-3.42-0.95
Debt to Equity 2.39-13.20-3.55-1.27-1.075.56-5.58-1.89-1.00-0.75-0.94-0.79-0.60-0.51-0.49
Debt Ratio 0.610.430.460.580.670.370.420.330.420.550.450.530.690.820.86
Equity Ratio 0.26-0.03-0.13-0.45-0.630.07-0.07-0.18-0.42-0.73-0.48-0.67-1.15-1.62-1.76
Times Interest Earned -13.74-8.00-4.58-4.86-3.26-3.30-3.53-5.36-4.07-4.35-3.83-3.20-4.36-3.42-0.95
Valuation
Enterprise Value 293.02M121.87M236.72M311.10M169.61M375.18M372.51M138.46M295.93M323.81M739.92M255.10M221.45M517.09M696.99M
Market Capitalization 431.61M329.77M434.06M466.99M299.69M624.55M589.05M522.72M621.03M602.91M1,077.46M555.22M436.62M669.52M835.01M
Return Ratios
Return on Sales 7.24%5.77%4.90%4.59%7.13%14.38%-12.92%-6.05%-4.22%-2.89%-1.86%
Return on Capital Employed -1.10%-1.18%-0.82%-0.63%-0.58%-0.61%-0.87%-1.00%-0.93%-1.09%-1.49%-1.40%
Return on Assets -1.08%-1.26%-0.90%-0.70%-0.62%-0.64%-0.88%-0.96%-0.87%-1.03%-1.21%-1.12%
Return on Equity 3.90%2.36%5.09%4.45%2.23%1.55%1.61%1.52%1.17%0.89%0.66%